Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × Reverse Transcriptase Polymerase Chain Reaction × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Rectal Neoplasms 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Multiple Myeloma 1 Liposarcoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡